TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | -2 | 4 | 22 | 10 | -3 | -29 | 0 |
| P | %wins | 0 | 100 | 100 | 100 | 0 | 0 | 50 | |||
| S | %ret | 1 | 1 | 1 | -7 | 0 | -3 | 3 | -26 | -22 | -11 |
| S | %wins | 100 | 100 | 100 | 0 | 100 | 100 | 83 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/10/13 16:20 | 12/6/13 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lipton Karen Shoos | MA | D | M.d | 145 | 8.16 | 33 | 18 | 13 | D | 751 | 342 | 57 | -1 | 4 | 1 | -11 | -7 | -7 | 0 | -3 | 3 | -26 | -22 | ||
12/10/13 16:20 | 12/6/13 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lipton Karen Shoos | MA | D | S.d | -434 | 24.50 | 33 | -18 | -57 | 13 | D | 751 | 342 | 57 | -1 | 4 | 1 | -11 | -7 | -7 | 0 | -3 | 3 | -26 | -22 | |
9/16/10 13:16 | 9/16/10 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lipton Karen Shoos | MA | D | P | 11 | 3.74 | 3 | 3 | New | 3 | D | -63 | -29 | -27 | -28 | -28 | -13 | 8 | 9 | -2 | 4 | 22 | 10 | -3 | -29 | |
5/17/06 10:42 | 5/15/06 | AVAN | Avant Immunotherapeutics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lipton Karen Shoos | MD | D | M.d | 5 | 1.23 | 0 | 4 | New | 4 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |